AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Glimnib M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

San-Pen Pharmaceuticals Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimnib M1 Tablet PR

Diabetic patients may benefit from Glymida M1, a dual-action antidiabetic medication. This formulation combines two agents to manage type 2 diabetes in adults, effectively regulating blood glucose. Glymida M1 should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Glymida M1 is one component of a comprehensive diabetes management plan, requiring dietary changes, regular exercise, and weight management as directed by your healthcare provider. Lifestyle adjustments are paramount to effective diabetes control. Hypoglycemia (low blood sugar) is a common side effect, presenting as sweating, dizziness, headache, or tremors. Maintain regular meals, carry a quick-acting glucose source (like sweets or juice), and avoid alcohol to mitigate this risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may also occur. Glymida M1 is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring and periodic blood tests (including blood cell counts and liver function assessments) are recommended.

Uses of Glimnib M1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimnib M1 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Administer Glimnib M1 Tablet PR with a meal.

Common Side effects of Glimnib M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimnib M1 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidance. Administer Glimnib M1 Tablet PR with a meal.

How Glimnib M1 Tablet PR works:

Glimnib M1 Tablet PR combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimnib M1 Tablet PR and alcohol is contraindicated due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimnib M1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The medication Glimnib M1 Tablet PR is contraindicated for breastfeeding mothers. Evidence indicates a potential for infant toxicity.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimnib M1 Tablet PR; dosage modification may be necessary. Severe kidney disease contraindicates Glimnib M1 Tablet PR use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimnib M1 Tablet PR cautiously, potentially requiring dose modification. Consultation with a physician is advised. For those with mild to moderate liver disease, Glimnib M1 Tablet PR is typically initiated at a low dosage; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimnib M1 Tablet PR :

Should you forget a Glimnib M1 Tablet PR dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimnib M1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimnib M1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimnib M1 Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimnib M1 Tablet PR and seek immediate medical attention.
Glimnib M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glimnib M1 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimnib M1 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Glimnib M1 Tablet PR can indeed lower blood sugar, potentially causing hypoglycemia. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, a rapid heart rate, and anxiety or shakiness. These are more likely if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimnib M1 Tablet PR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimnib M1 Tablet PR
117
MRP 143
18% off